
    
      Patients with aorto-iliac occlusive disease (TASC, type D) operated with a totally
      laparoscopic aortobifemoral bypass operation and open aortobifemoral bypass operation will be
      followed up and the results will be compared between the two procedures on the basis of the
      primary endpoint, a composite endpoint defined as a combined incidence of systemic morbidity,
      graft thrombosis and all-cause mortality.

      Secondary endpoints like length of hospital stay, operation time, bleeding time shall also be
      considered.

      Besides short form- 36 (SF-36) shall be used for the evaluation of patients health related
      quality of life, preoperatively,1,3,and 6 months and 1 year post-operatively.

      Early, midterm and long time results shall be followed.
    
  